Protocol Ledger

NCT05150704 · Phase III · RECRUITING

MYTHS - MYocarditis THerapy With Steroids

Interventional Phase III clinical trial protocol NCT05150704 sponsored by Niguarda Hospital in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-10-07 Enrollment: 288 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05150704
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)288 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05150704
Protocol FieldVerified Registry Value
NCT IdentifierNCT05150704
Consolidated Lead SponsorNiguarda Hospital
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment288 participants (ESTIMATED)
Registered Start Date2021-10-07
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT05150704
Hospital Research SiteLocationSite Profile
UC San Diego Health and Moores Cancer CenterSan Diego, CAOpen Hospital Dossier ->
University of VirginiaCharlottesville, VAOpen Hospital Dossier ->
Virginia Commonwealth UniversityRichmond, VAOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI